logo
logo
AI + EXCLUSIVE DATA

AI identifies M&A opportunities from proprietary sources

Our AI analyzes exclusive acquisition data to predict which merged companies need YOUR integration capabilities.

10-25 M&A leads daily • Tech stack analysis • Integration scoring
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + exclusive M&A intelligence
✓Post-merger opportunity analysis
INDUSTRY FIRST

Alembic Pharmaceuticals acquires Utility Therapeutics

Jul 03, 2025•about 2 months ago

Acquiring Company

Alembic Pharmaceuticals

Acquired Company

Utility Therapeutics

VadodaraAltrinchamPharmaceuticalManufacturingBiotechnologyHealth Care

Description

Alembic Pharmaceuticals has acquired Utility Therapeutics for $12 million. The acquisition will be completed in a staggered manner based on milestone achievements. Utility Therapeutics specializes in developing treatments for urinary tract infections. This acquisition enhances Alembic's portfolio in the pharmaceutical sector.

Company Information

Company

Alembic Pharmaceuticals

Location

Vadodara, Gujarat, India

About

Alembic Pharmaceuticals Inc. is a leading pharmaceutical company in India. It specializes in the manufacturing and marketing of various pharmaceutical products. The company focuses on ensuring high-quality standards and innovation. Alembic aims to improve healthcare outcomes through its diverse portfolio.

Company News

(7 articles)
Thu, 28 Sep 2017 02:56:22 GMT

Alembic Pharmaceuticals - Crunchbase

Tue, 13 Aug 2024 07:00:00 GMT

Alembic Pharmaceuticals announces USFDA Final Approval for Nelarabine Injection - Microbioz India

Sat, 12 Apr 2025 08:40:55 GMT

Alembic Pharmaceuticals Ltd - Fortune India

Tue, 13 Aug 2019 07:00:00 GMT

New Dorzolamide Hydrochloride Ophthalmic Solution Receives FDA Approval - Pharmacy Times

Tue, 12 Nov 2024 08:00:00 GMT

Alembic honoured with Guinness World Record for Hypertension Awareness Milestone - Microbioz India

Mon, 08 Feb 2021 08:00:00 GMT

Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ™), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL - Business Wire

Fri, 21 Jul 2023 08:52:44 GMT

Alembic Pharmaceuticals Ltd - Equitypandit

FundzWatch™ Score

64
High M&A Activity

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed